Even with Inflation Reduction Act (IRA)-related pressure looming for its top product, Teva Pharmaceuticals is continuing to ...

Teva shares jumped 12% after Q3 earnings beat estimates, driven by strong branded drug sales led by Austedo and solid ...

Since the start of the month, several drug recalls have entered the FDA’s periphery, affecting products ranging from hospital ...

TEL AVIV, Israel, July 31, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today reported results for the quarter ended June 30, 2024. Mr. Richard Francis, Teva's ...

A generic blood pressure drug called prazosin, made by Teva Pharmaceuticals, is being recalled by the Food and Drug ...

Teva Pharmaceutical Industries Ltd (TEVA) reports its 11th consecutive quarter of growth, driven by innovative products, ...

TEL AVIV, Feb 13 (Reuters) - Teva Pharmaceutical Industries Ltd. said on Tuesday that fourth-quarter net earnings rose, helped by sales of new products in the United States and its acquisition of IVAX ...

Teva Pharmaceuticals recalled 13 lots of fentanyl buccal tablets, a Type II substance, because of omitted safety updates on its medication guide, the FDA said April 28. The agency said the main ...

Teva stock rocketed into a profit-taking zone Wednesday after the company put up a big sales beat for its drug Austedo in the ...

The person behind the modification was JPMorgan Chase analyst Chris Schott, who pushed up his Teva stock recommendation one notch from neutral to overweight (read: buy). He also bumped his price ...

Phoenix Financial recently acquired more than 3.5 million additional shares of Teva Pharmaceutical Industries in the third ...